Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000013

President and CEO gave up 3,324 shares (to pay taxes)

  • President and CEO acquired 99,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Doshi Dipal President and CEO 2023-03-01 Grant or award +99,300 261,135 D: show line 1 in the form
Doshi Dipal President and CEO 2023-03-02 Shares withheld for taxes −3,324 $11.60 $38,546 257,811 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Doshi Dipal President and CEO 2023-03-01 Grant or award · Stock Option (Right to Buy) +150,500 150,500 D: show line 3 in the form
Loading xslF345X03/wf-form4_167787923707368.xml…